Interindividual variability of CYP2C19-catalyzed drug metabolism due to differences in gene diplotypes and cytochrome P450 oxidoreductase content

The Pharmacogenomics Journal
Y ShirasakaK E Thummel

Abstract

Large interindividual variability has been observed in the metabolism of CYP2C19 substrates in vivo. The study aimed to evaluate sources of this variability in CYP2C19 activity, focusing on CYP2C19 diplotypes and the cytochrome P450 oxidoreductase (POR). CYP2C19 gene analysis was carried out on 347 human liver samples. CYP2C19 activity assayed using human liver microsomes confirmed a significant a priori predicted rank order for (S)-mephenytoin hydroxylase activity of CYP2C19*17/*17 > *1B/*17 > *1B/*1B > *2A/*17 > *1B/*2A > *2A/*2A diplotypes. In a multivariate analysis, the CYP2C19*2A allele and POR protein content were associated with CYP2C19 activity. Further analysis indicated a strong effect of the CYP2C19*2A, but not the *17, allele on both metabolic steps in the conversion of clopidogrel to its active metabolite. The present study demonstrates that interindividual variability in CYP2C19 activity is due to differences in both CYP2C19 protein content associated with gene diplotypes and the POR concentration.The Pharmacogenomics Journal advance online publication, 1 September 2015; doi:10.1038/tpj.2015.58.

References

Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Feb 22, 1994·Biochemistry·J A GoldsteinB I Ghanayem
May 26, 1999·Clinical Pharmacology and Therapeutics·T FurutaT Ishizaki
Sep 6, 2000·Pharmacology·P J Wedlund
May 4, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S FurutaH Sano
Nov 17, 2001·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·G W WarrenR A Blouin
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Judy L RaucyJerome M Lasker
Aug 7, 2004·Bioinformatics·J C BarrettM J Daly
Sep 6, 2005·Drug Metabolism and Pharmacokinetics·Hiromi Fukushima-UesakaJun-Ichi Sawada
Mar 18, 2006·Molecular Endocrinology·David J Waxman, Caitlin O'Connor
Sep 6, 2006·Clinical Pharmacology and Therapeutics·Reginald F FryeRobert A Branch
Sep 12, 2006·International Journal of Clinical Pharmacology and Therapeutics·U Klotz
Apr 25, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N HaniokaS Narimatsu
Dec 1, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Robert S Foti, Jan L Wahlstrom
Feb 26, 2008·British Journal of Clinical Pharmacology·R Michael BaldwinLeif Bertilsson
Jul 26, 2008·European Journal of Clinical Pharmacology·Staffan Ohlsson RosenborgErik Eliasson
Dec 25, 2008·The New England Journal of Medicine·Jessica L MegaMarc S Sabatine
Jun 2, 2009·Molecular Pharmacology·David J Waxman, Minita G Holloway
Aug 8, 2009·Nature Protocols·F Peter GuengerichQian Cheng
Mar 18, 2010·British Journal of Clinical Pharmacology·Alain Li-Wan-PoJames Lithgow
Oct 29, 2010·The New England Journal of Medicine·Guillaume ParéJohn W Eikelboom
Dec 15, 2010·British Journal of Clinical Pharmacology·Michael J Dolton, Andrew J McLachlan
Jul 1, 2011·Clinical Pharmacology and Therapeutics·S A ScottUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Sep 16, 2011·Journal of Clinical Pharmacy and Therapeutics·D AnichavezhiC Adithan
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Joseph McGraw, Donald Waller
Feb 4, 2012·Current Drug Metabolism·Bhavik S ShahAnita A Mehta
Mar 16, 2012·European Journal of Clinical Pharmacology·Barbara Gawrońska-SzklarzMarek Drozdzik
Feb 16, 2013·Drug Metabolism and Drug Interactions·Jonathan C SanfordDanxin Wang
Mar 15, 2013·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Apr 27, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yoshiyuki ShirasakaNina Isoherranen
Jul 3, 2013·Journal of Thrombosis and Haemostasis : JTH·J P LewisA R Shuldiner

❮ Previous
Next ❯

Citations

Dec 13, 2016·Journal of Pharmaceutical Sciences·Bhagwat PrasadDeepak Kumar Bhatt
Feb 18, 2017·Molecular Pharmaceutics·Jie GaoHai-Ling Qiao
Jul 1, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yuki HoriTetsuya Aiba
Aug 19, 2017·The Journal of Pharmacology and Experimental Therapeutics·Meijuan XuBhagwat Prasad
Nov 7, 2016·The Journal of Pharmacology and Experimental Therapeutics·Julie-Anne TannerRachel F Tyndale
May 19, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Mayur K LadumorBhagwat Prasad
Apr 1, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Deepak Kumar BhattBhagwat Prasad
Jun 14, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Deepak Kumar BhattBhagwat Prasad
Jan 19, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Timothy WongKenneth E Thummel
Feb 1, 2020·Clinical and Translational Science·Lingxin ZhangRichard Weinshilboum
Apr 18, 2018·Pharmacological Reports : PR·Ádám Ferenc KissKatalin Monostory
Dec 13, 2016·Pharmaceutical Research·Geoffrey T Tucker
Aug 21, 2020·Scientific Reports·Ole JensenJürgen Brockmöller
Feb 27, 2021·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lindsay M HendersonKenneth E Thummel
Oct 7, 2020·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Manisha NautiyalMerrie Mosedale
Sep 22, 2020·Molecular Pharmaceutics·Abdul BasitBhagwat Prasad
Aug 15, 2021·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Christoph WenzelStefan Oswald

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
Protein Assay

Software Mentioned

MULTI
Haploview
GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.